Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Sep 2026.
- Largest single sale: $2.7M (19,836 shares) of Moderna on Sep 10, 2026. Filing
- Last sale before this period: Nov 29, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Moderna (MRNA) | Chief Financial Officer | Oct 7, 2022 | Oct 7, 2026 |
| Revvity (RVTY) | Former Senior Vice President and Chief Financial Officer | May 17, 2018 | Jun 27, 2022 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 5, 2026, Moderna: 1,454 shares vested; 704 shares withheld by the company for taxes. 1 filing: 1
- Sep 10, 2026, Moderna: sold 34,836 shares for $4.7M, under a disclosed plan; 19,836 shares acquired by exercising options. 1 filing: 1
- Sep 4, 2026, Moderna: 11,797 shares vested; 5,704 shares withheld by the company for taxes. 1 filing: 1
- Sep 1, 2026, Moderna: 2,475 shares vested; 1,197 shares withheld by the company for taxes. 1 filing: 1
- Aug 28, 2026, Moderna: 329 shares vested; 160 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.